Cost‐Effectiveness Analysis of Omalizumab Combined With Standard of Care in Treating Moderate to Severe Asthma Children in China

Documenti analoghi

• Cost‐Effectiveness Analysis of Treatments for Children With Uncontrolled Asthma Symptoms Despite Inhaled Corticosteroids
  di: Giovanna Culeddu, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Dupilumab in Children With Moderate‐to‐Severe Asthma: A Systematic Review of Emerging Phase 3 Evidence
  di: Almutairi Ghadah, et al.
  Pubblicazione: (2025)
• Remission in Children Receiving Biologic Therapy for Severe Asthma
  di: Eilidh Bruce, et al.
  Pubblicazione: (2025)
• Intravenous Salbutamol for Children With Severe Acute Asthma on a Dutch Pediatric Ward: An Effective and Child‐Friendly Alternative
  di: I. M. Schellekens, et al.
  Pubblicazione: (2025)
• The Role of Vitamin D in Severity and Control of Asthma in Children and Adolescents: A Systematic Review and Meta‐Analysis
  di: Joelia M. Ladeira, et al.
  Pubblicazione: (2026)